ARANO, LLC
🇺🇸United States
Clinical Trials
19
Active:0
Completed:15
Trial Phases
5 Phases
Phase 1:3
Phase 2:3
Phase 3:1
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (18 trials with phase data)• Click on a phase to view related trials
Not Applicable
10 (55.6%)Phase 1
3 (16.7%)Phase 2
3 (16.7%)Phase 3
1 (5.6%)Phase 4
1 (5.6%)ZOOM First Impressions
Not Applicable
Withdrawn
- Conditions
- AttractivenessFirst ImpressionsSelf Esteem
- First Posted Date
- 2023-02-22
- Last Posted Date
- 2023-02-22
- Lead Sponsor
- DeNova Research
- Registration Number
- NCT05739721
- Locations
- 🇺🇸
DeNova Research, Chicago, Illinois, United States
Ethnic Lip Augmentation With Hyaluronic Acid Filler
Phase 3
Completed
- Conditions
- Lip AugmentationLip Fullness
- Interventions
- Drug: Volbella or Juvederm Ultra XC filler
- First Posted Date
- 2023-02-16
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- DeNova Research
- Target Recruit Count
- 20
- Registration Number
- NCT05730543
- Locations
- 🇺🇸
DeNova Research, Chicago, Illinois, United States
First Impressions and Attractiveness Levels of Smiling Individuals With and Without a Mask
Completed
- Conditions
- AttractivenessFirst Impressions
- First Posted Date
- 2022-04-25
- Last Posted Date
- 2022-04-25
- Lead Sponsor
- DeNova Research
- Target Recruit Count
- 808
- Registration Number
- NCT05343559
- Locations
- 🇺🇸
DeNova Research, Chicago, Illinois, United States
Non-Surgical Rhinoplasty Using PDO Threads
Not Applicable
Completed
- Conditions
- Nasal Defect
- First Posted Date
- 2021-02-24
- Last Posted Date
- 2021-10-12
- Lead Sponsor
- DeNova Research
- Target Recruit Count
- 10
- Registration Number
- NCT04769427
- Locations
- 🇺🇸
DeNova Research, Chicago, Illinois, United States
Impact of Botox Treatment Into the Upper One Third of the Face an Area on Mood and Self -Appearance Satisfaction
Phase 1
Completed
- Conditions
- Mood
- Interventions
- Drug: PlaceboDrug: Botulinum Neurotoxin
- First Posted Date
- 2020-06-19
- Last Posted Date
- 2021-03-15
- Lead Sponsor
- DeNova Research
- Target Recruit Count
- 45
- Registration Number
- NCT04439825
- Locations
- 🇺🇸
DeNova Research, Chicago, Illinois, United States
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found